Cash From Operating Activities - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ryvu Therapeutics SA
Cash from Operating Activities Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Cash from Operating Activities
-zł94.5m
CAGR 3-Years
-165%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Cash from Operating Activities
-zł948k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
9%
M
Medicofarma Biotech SA
WSE:MDB
Cash from Operating Activities
zł4.8k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Cash from Operating Activities
zł96m
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Cash from Operating Activities?
Cash from Operating Activities
-94.5m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Cash from Operating Activities amounts to -94.5m PLN.

What is Ryvu Therapeutics SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-10%

The average annual Cash from Operating Activities growth rates for Ryvu Therapeutics SA have been -165% over the past three years , -10% over the past five years .

Back to Top